SCHEMBL14334122

SCHEMBL14334122

CC(=O)N1CCC(Oc2ncccc2N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14334240 0.85 CYP4A11 (0.49) —
SCHEMBL14334120 0.85 ROCK2 (0.48) —
SCHEMBL14335009 0.84 GPR119 (0.54) —
SCHEMBL14334296 0.82 IRAK4 (0.52) —
SCHEMBL14334929 0.82 KDM5A (0.40) —
SCHEMBL14334914 0.82 NAMPT (0.45) —
SCHEMBL14334210 0.80 CHEK2 (0.43) —
SCHEMBL14377360 0.80 PIK3CD (0.55) —
SCHEMBL14334113 0.80 PIK3CD (0.55) —
SCHEMBL20687907 0.80 ALOX5AP (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012176123-A1 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2012-12-27 — — WO disclosed
Send feedback